1307458

Danielle A. Shiller, D.O. — FEI 3042220169

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 5, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Grayslake, IL (United States)

Additional Details

Clinical BA/BE